NGS Tumor Gene Analysis Software Market, Global Outlook and Forecast 2023-2029

Report ID: MMG302863 | Category: Service & Software | Pages: 67 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This research report provides a comprehensive analysis of the NGS Tumor Gene Analysis Software market, focusing on the current trends, market dynamics, and future prospects. The report explores the global NGS Tumor Gene Analysis Software market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of NGS Tumor Gene Analysis Software, challenges faced by the industry, and potential opportunities for market players.
The global NGS Tumor Gene Analysis Software market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The NGS Tumor Gene Analysis Software market presents opportunities for various stakeholders, including Hospitals and Health Systems, Research Institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in NGS Tumor Gene Analysis Software market. Additionally, the growing consumer demand present avenues for market expansion.
The global NGS Tumor Gene Analysis Software market was valued at US$ 1423.3 million in 2022 and is projected to reach US$ 4591.9 million by 2029, at a CAGR of 18.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the NGS Tumor Gene Analysis Software market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the NGS Tumor Gene Analysis Software market.
Market Overview: The report provides a comprehensive overview of the NGS Tumor Gene Analysis Software market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Non-Small Cell Lung Cancer, Human 6 Gene Mutations), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the NGS Tumor Gene Analysis Software market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the NGS Tumor Gene Analysis Software market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the NGS Tumor Gene Analysis Software market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the NGS Tumor Gene Analysis Software market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the NGS Tumor Gene Analysis Software market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the NGS Tumor Gene Analysis Software market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for NGS Tumor Gene Analysis Software, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the NGS Tumor Gene Analysis Software market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
NGS Tumor Gene Analysis Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Non-Small Cell Lung Cancer
Human 6 Gene Mutations
Human 12 Gene Mutations
Other
Market segment by Application
Hospitals and Health Systems
Research Institute
Other
Global NGS Tumor Gene Analysis Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Roche
Illumina
Thermo Fisher Scientific
BGI Group
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
GTH.O
Golden Helix, Inc
Diatech Pharmacogenetics
ViennaLab Diagnostics GmbH
3D Medicines
Outline of Major Chapters:
Chapter 1: Introduces the definition of NGS Tumor Gene Analysis Software, market overview.
Chapter 2: Global NGS Tumor Gene Analysis Software market size in revenue.
Chapter 3: Detailed analysis of NGS Tumor Gene Analysis Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NGS Tumor Gene Analysis Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 NGS Tumor Gene Analysis Software Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global NGS Tumor Gene Analysis Software Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global NGS Tumor Gene Analysis Software Overall Market Size
    2.1 Global NGS Tumor Gene Analysis Software Market Size: 2022 VS 2029
    2.2 Global NGS Tumor Gene Analysis Software Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top NGS Tumor Gene Analysis Software Players in Global Market
    3.2 Top Global NGS Tumor Gene Analysis Software Companies Ranked by Revenue
    3.3 Global NGS Tumor Gene Analysis Software Revenue by Companies
    3.4 Top 3 and Top 5 NGS Tumor Gene Analysis Software Companies in Global Market, by Revenue in 2022
    3.5 Global Companies NGS Tumor Gene Analysis Software Product Type
    3.6 Tier 1, Tier 2 and Tier 3 NGS Tumor Gene Analysis Software Players in Global Market
        3.6.1 List of Global Tier 1 NGS Tumor Gene Analysis Software Companies
        3.6.2 List of Global Tier 2 and Tier 3 NGS Tumor Gene Analysis Software Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global NGS Tumor Gene Analysis Software Market Size Markets, 2022 & 2029
        4.1.2 Non-Small Cell Lung Cancer
        4.1.3 Human 6 Gene Mutations
        4.1.4 Human 12 Gene Mutations
        4.1.5 Other
    4.2 By Type - Global NGS Tumor Gene Analysis Software Revenue & Forecasts
        4.2.1 By Type - Global NGS Tumor Gene Analysis Software Revenue, 2018-2023
        4.2.2 By Type - Global NGS Tumor Gene Analysis Software Revenue, 2024-2029
        4.2.3 By Type - Global NGS Tumor Gene Analysis Software Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global NGS Tumor Gene Analysis Software Market Size, 2022 & 2029
        5.1.2 Hospitals and Health Systems
        5.1.3 Research Institute
        5.1.4 Other
    5.2 By Application - Global NGS Tumor Gene Analysis Software Revenue & Forecasts
        5.2.1 By Application - Global NGS Tumor Gene Analysis Software Revenue, 2018-2023
        5.2.2 By Application - Global NGS Tumor Gene Analysis Software Revenue, 2024-2029
        5.2.3 By Application - Global NGS Tumor Gene Analysis Software Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global NGS Tumor Gene Analysis Software Market Size, 2022 & 2029
    6.2 By Region - Global NGS Tumor Gene Analysis Software Revenue & Forecasts
        6.2.1 By Region - Global NGS Tumor Gene Analysis Software Revenue, 2018-2023
        6.2.2 By Region - Global NGS Tumor Gene Analysis Software Revenue, 2024-2029
        6.2.3 By Region - Global NGS Tumor Gene Analysis Software Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America NGS Tumor Gene Analysis Software Revenue, 2018-2029
        6.3.2 US NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.3.3 Canada NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.3.4 Mexico NGS Tumor Gene Analysis Software Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe NGS Tumor Gene Analysis Software Revenue, 2018-2029
        6.4.2 Germany NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.4.3 France NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.4.4 U.K. NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.4.5 Italy NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.4.6 Russia NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.4.7 Nordic Countries NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.4.8 Benelux NGS Tumor Gene Analysis Software Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia NGS Tumor Gene Analysis Software Revenue, 2018-2029
        6.5.2 China NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.5.3 Japan NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.5.4 South Korea NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.5.5 Southeast Asia NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.5.6 India NGS Tumor Gene Analysis Software Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America NGS Tumor Gene Analysis Software Revenue, 2018-2029
        6.6.2 Brazil NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.6.3 Argentina NGS Tumor Gene Analysis Software Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa NGS Tumor Gene Analysis Software Revenue, 2018-2029
        6.7.2 Turkey NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.7.3 Israel NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.7.4 Saudi Arabia NGS Tumor Gene Analysis Software Market Size, 2018-2029
        6.7.5 UAE NGS Tumor Gene Analysis Software Market Size, 2018-2029
7 NGS Tumor Gene Analysis Software Companies Profiles
    7.1 Roche
        7.1.1 Roche Company Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche NGS Tumor Gene Analysis Software Major Product Offerings
        7.1.4 Roche NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.1.5 Roche Key News & Latest Developments
    7.2 Illumina
        7.2.1 Illumina Company Summary
        7.2.2 Illumina Business Overview
        7.2.3 Illumina NGS Tumor Gene Analysis Software Major Product Offerings
        7.2.4 Illumina NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.2.5 Illumina Key News & Latest Developments
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Company Summary
        7.3.2 Thermo Fisher Scientific Business Overview
        7.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Major Product Offerings
        7.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.3.5 Thermo Fisher Scientific Key News & Latest Developments
    7.4 BGI Group
        7.4.1 BGI Group Company Summary
        7.4.2 BGI Group Business Overview
        7.4.3 BGI Group NGS Tumor Gene Analysis Software Major Product Offerings
        7.4.4 BGI Group NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.4.5 BGI Group Key News & Latest Developments
    7.5 Novogene
        7.5.1 Novogene Company Summary
        7.5.2 Novogene Business Overview
        7.5.3 Novogene NGS Tumor Gene Analysis Software Major Product Offerings
        7.5.4 Novogene NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.5.5 Novogene Key News & Latest Developments
    7.6 Geneseeq
        7.6.1 Geneseeq Company Summary
        7.6.2 Geneseeq Business Overview
        7.6.3 Geneseeq NGS Tumor Gene Analysis Software Major Product Offerings
        7.6.4 Geneseeq NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.6.5 Geneseeq Key News & Latest Developments
    7.7 AmoyDx
        7.7.1 AmoyDx Company Summary
        7.7.2 AmoyDx Business Overview
        7.7.3 AmoyDx NGS Tumor Gene Analysis Software Major Product Offerings
        7.7.4 AmoyDx NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.7.5 AmoyDx Key News & Latest Developments
    7.8 Burning Rock Medicine
        7.8.1 Burning Rock Medicine Company Summary
        7.8.2 Burning Rock Medicine Business Overview
        7.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Major Product Offerings
        7.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.8.5 Burning Rock Medicine Key News & Latest Developments
    7.9 GTH.O
        7.9.1 GTH.O Company Summary
        7.9.2 GTH.O Business Overview
        7.9.3 GTH.O NGS Tumor Gene Analysis Software Major Product Offerings
        7.9.4 GTH.O NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.9.5 GTH.O Key News & Latest Developments
    7.10 Golden Helix, Inc
        7.10.1 Golden Helix, Inc Company Summary
        7.10.2 Golden Helix, Inc Business Overview
        7.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Major Product Offerings
        7.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.10.5 Golden Helix, Inc Key News & Latest Developments
    7.11 Diatech Pharmacogenetics
        7.11.1 Diatech Pharmacogenetics Company Summary
        7.11.2 Diatech Pharmacogenetics Business Overview
        7.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Major Product Offerings
        7.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.11.5 Diatech Pharmacogenetics Key News & Latest Developments
    7.12 ViennaLab Diagnostics GmbH
        7.12.1 ViennaLab Diagnostics GmbH Company Summary
        7.12.2 ViennaLab Diagnostics GmbH Business Overview
        7.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Major Product Offerings
        7.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.12.5 ViennaLab Diagnostics GmbH Key News & Latest Developments
    7.13 3D Medicines
        7.13.1 3D Medicines Company Summary
        7.13.2 3D Medicines Business Overview
        7.13.3 3D Medicines NGS Tumor Gene Analysis Software Major Product Offerings
        7.13.4 3D Medicines NGS Tumor Gene Analysis Software Revenue in Global Market (2018-2023)
        7.13.5 3D Medicines Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

NGS Tumor Gene Analysis Software Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?